Evidence map›Paper›PMID 36816240›Full record

ArticleHeliyon2023

Establishing local manufacture of PPE for healthcare workers in the time of a global pandemic.

Anastasia Nilasaroya, Alan Matthew Kop, Ryan Christopher Collier, Brendan Kennedy, Lachlan James Kelsey, Faz Pollard, Jennifer Fong Ha, David Anthony Morrison

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Anastasia NilasaroyaCentre for Implant Technology and Retrievals Analysis (CITRA), Department of Medical Engineering and Physics, Royal Perth Hospital, Perth, Western Australia, 6000, Australia.
Alan Matthew KopCentre for Implant Technology and Retrievals Analysis (CITRA), Department of Medical Engineering and Physics, Royal Perth Hospital, Perth, Western Australia, 6000, Australia.
Ryan Christopher CollierCentre for Implant Technology and Retrievals Analysis (CITRA), Department of Medical Engineering and Physics, Royal Perth Hospital, Perth, Western Australia, 6000, Australia.
Brendan KennedyBRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia, 6009, Australia and Centre for Medical Research, The University of Western Australia, Crawley, Western Australia, 6009, Australia.
Lachlan James KelseyVascular Engineering Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, The University of Western Australia, Crawley, Western Australia, 6009, Australia.
Faz PollardAdarsh Australia, 6 Crocker Drive, Malaga, Western Australia, 6090, Australia.
Jennifer Fong HaDepartment of Paediatrics Otolaryngology Head & Neck Surgery, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, Western Australia, 6009, Australia.
David Anthony MorrisonCentre for Implant Technology and Retrievals Analysis (CITRA), Department of Medical Engineering and Physics, Royal Perth Hospital, Perth, Western Australia, 6000, Australia.
Royal Perth Hospital · AUAustralian Research Council · AUMurdoch University · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A face shield is a secondary personal protective equipment (PPE) for healthcare workers (HCW). Worn with the appropriate face masks/respirators, it provides short term barrier protection against potentially infectious droplet particles. Coronavirus disease 2019 (COVID-19) caused a spike in demand for PPE, leading to a shortage and risking the safety of HCW. Transport restrictions further challenged the existing PPE supply chain which has been reliant on overseas-based manufacturers. Despite the urgency in demand, PPE must be properly tested for functionality and quality. We describe the establishment of local face shields manufacture in Western Australia to ensure adequate PPE for HCW. Ten thousand face shields for general use (standard) and for ear, nose and throat (ENT) specialist use were produced. Materials and design considerations are described, and the face shields were vigorously tested to the relevant Standards to ensure their effectiveness as a protective barrier, including splash and impact resistance. Comparative testing with traditional and other novel face shields was also undertaken. Therapeutic Goods Administration (TGA) licence was obtained to manufacture and supply the face shields as a Class I medical device. The swiftness of process is a credit to collaboration from industry, academia and healthcare.

Indexed as

AS/NZS, Australian/New Zealand StandardCOVID-19COVID-19, coronavirus disease 2019ENT, ear, nose and throatHCW, healthcare workersISO, International Organization for StandardizationManufacturingMedical devicePETG, polyethylene terephthalate glycolPPE, personal protective equipmentQuality controlTGA, Therapeutic Goods Administration

Identifiers

PMID36816240
PMCPMC9922675
OpenAlexW4320497998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.